Research Funding ResourcesExplore this section to find information on research funding opportunities from the National Institutes of Health and other sources
The National Health Council just announced the availability of a database that will help link unfunded NIH applications with potential nongovernmental funding sources.
NIH medical and behavioral research grant policies, guidelines, and funding opportunities including the NIH Guide for Grants and Contracts.NIH Research Portfolio Online Reporting Tool Expenditure & Results (RePORTER)
Use the RePORTER database to find information on all NIH-funded research activities. Some of the studies may be enrolling participants, while others involve only laboratory experiments.grants.gov
A single governmentwide source for information about grants programs across the Federal government.NIH Center for Scientific Review (CSR)
The Center for Scientific Review (CSR) is the portal for NIH grant applications and their review for scientific merit. We organize the peer review groups or study sections that evaluate the majority (70%) of the research grant applications sent to NIH. We also receive all grant applications for NIH, as well as for some other components of the U.S. Department of Health and Human Services (DHHS). Since 1946, our mission has remained clear and timely: to see that NIH grant applications receive fair, independent, expert, and timely reviews -- free from inappropriate influences -- so NIH can fund the most promising research.NIH Small Business Funding Opportunities (SBIR and STTR)
Resources available through the Small Business Innovation Research and the Small Business Technology Transfer programs.National Organization for Rare Disorders (NORD)
NORD's Research Program provides seed money grants to academic scientists for clinical studies related to the development of diagnostics or treatments of rare diseases. Requests for proposals are posted once a year in the late winter or early spring. NORD's Research Program also includes the NORD/Roscoe Brady Lysosomal Storage Diseases Fellowships.Back to top National Marfan Foundation
The Marfan Foundation Grant Program for 2014 is requesting applications for the Faculty Grant Program. SPECIAL AREAS OF INTEREST INCLUDE basic research, translational studies, and clinical studies in cardiovascular, genetic, orthopedic, and ophthalmological areas utilizing synergistic collaborations; integration of novel theories from non-traditional researchers into established paradigms; novel animal model systems; innovation; and the distillation of knowledge into practical new therapies for Marfan syndrome and related disorders. Special consideration is given to proposals in non-cardiac disciplines and clinical research areas. AWARDS are determined based on proposal evaluations by The Marfan Foundation's Scientific Advisory Board with the approval of the Foundation's Board of Directors. No overhead or indirect costs are considered. Proposals must be prepared according to the Foundation's guidelines and must be submitted electronically via our website at Marfan.org.Conquering the Histiocytic Disorders: Requests for Research Proposals
The Histiocytosis Association funded more than $550,000 in scientific research in 2012 and 2013. Applications for funding in 2014 will be accepted beginning in May 2014.Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension
The mission of the Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension (PAH) is to support innovative scientific research that will advance knowledge in the field of pulmonary arterial hypertension, or PAH. Gilead Sciences, Inc. hopes that the research supported by these awards will enhance understanding of pulmonary arterial hypertension.National MPS Society 2014 Research Grants Announced
The National MPS Society funds research that may lead to treatments for MPS diseases and solicits applications for innovative research projects that involve basic research, translational studies and clinical research. Special consideration will be given to new investigators.PWSA (USA) 2014 Grant Submission Information & Requirements
Prader-Willi Syndrome Association (USA) ["PWSA (USA)"] is pleased to offer grant assistance for scientific researchers with an interest in improving the lives of those with Prader-Willi syndrome (PWS). PWSA (USA) is seeking to fund projects for a maximum of $75,000 total per project for a 1-2 year grant support aimed at discovering and developing treatments, cures and technologies benefiting those with Prader-Willi syndrome. PWSA (USA) is especially interested in supporting research projects that have the potential for immediate and high impact to the PWS community. The research committee has decided that PWSA(USA) will support research-based translational grants or those showing high promise for translating basic biomedical knowledge to clinical application. The goal is to fast-track better treatment for the syndrome.Vasculitis Foundation
The purpose of the Vasculitis Foundation Research Grant Program is to provide 1- or 2-year seed grants to support pilot studies in researching the etiology; epidemiology; diagnosis; treatment; including approaches that would prevent complications; and development of coping skills for living with this disease.Histiocytosis Association of America’s Research Program
The Histiocytosis Association of America’s Research Program seeks to attain its goal of a cure through a variety of efforts, the foremost being the direct funding of both basic and clinical scientific research projects. Through the annual Research Grant Awards, the Association supports basic scientific research into understanding the function of cells and the disease process.
Beginning January 4, the 2010 Request for Proposals will be available on the Association’s website at www.histio.org/requestforproposals. Information regarding the application deadline, notification of awarded grants, and maximum funding request can be found on this page as well. Researchers considering applying to the Association’s research grant program are encouraged to direct any questions to the Association at firstname.lastname@example.org, or by phone at 1 800-548-2758 (toll-free in the United States and Canada only) or 856-589-6606.
MDA's research program is a dedicated partnership between scientists and concerned citizens aimed at conquering neuromuscular disease. MDA combats some 40 neuromuscular diseases through a worldwide extramural research program that includes basic, clinical, and translational research efforts as well as a clinical research training grant program. MDA's focus is not simply to fund good science but to fund good science aimed at developing treatments and therapies for neuromuscular disease.National Ataxia Foundation (NAF)
The National Ataxia Foundation funds four types of research grants for new and innovative studies that are relevant to the cause, pathogenesis, or treatment of the hereditary or sporadic ataxias.NephCure Foundation
The NephCure Foundation is the only organization devoted exclusively to supporting research into the cause of and cure for Idiopathic Nephrotic Syndrome and primary Focal Segmental Glomerulosclerosis (FSGS). Comprised of patients, their families and friends, researchers, physicians, and other health care professionals, NephCure has a growing program of scientific support.The Aplastic Anemia & MDS International Foundation
The Aplastic Anemia MDS International Foundation offers 2-year research grants of $30,000 per year to advance the understanding and treatment of bone marrow failure diseases, including aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH).The research grant program application and guidelines are available at the MDSIF Web site.The Progeria Research Foundation (PRF)
Awards of up to $50,000 per year for up to 2 years are available from PRF to support investigators for basic science research aimed at developing effective treatments and/or a cure for Hutchinson-Gilford Progeria Syndrome and its aging-related disorders. Principal investigators must hold postdoctoral positions or beyond. Awards will be granted only to applicants affiliated with institutions with 501(c)3 status or the equivalent for foreign institutions.United Mitochondrial Disease Foundation (UMDF)
The UMDF promotes research and education for the diagnosis, treatment, and cure of mitochondrial disorders and provides support to affected individuals and families. Through its Research Program, UMDF awards more than $1 million per year in grants to scientists conducting basic research into mitochondrial disorders as well as for clinical studies focusing on diagnosis and treatment.Funding Opportunity from FPWR in Prader-Willi Research
The Foundation for Prader-Willi Research (FPWR), a nonprofit organization dedicated to supporting research to advance the understanding and treatment of Prader-Willi syndrome (PWS), announces the availability of funds to support innovative research relevant to PWS. FPWR is particularly interested in supporting projects that will lead to new interventions to alleviate the symptoms associated with PWS.
Priority will be given to the following areas of research, although alternative areas of high scientific merit will also be considered:
- Molecular basis of the PWS phenotype
- Regulation of appetite and energy homeostasis in individuals with PWS; development and evaluation of therapeutic interventions to regulate appetite and satiety in PWS
- Etiology of medical, behavioral and psychiatric complications in PWS; development and evaluation of therapeutic interventions
- Development of novel therapeutic interventions using in vitro and in vivo models of PWS
A more complete list of research priorities may be found here.
Funds Available: Applicants may request up to $100,000 USD in direct costs for the initial year of support, with the possibility of a second year of funding upon competitive renewal. Indirect costs of up to 8% are allowed.The Alport Syndrome Research Funding Program
The Alport Syndrome Foundation (ASF), the Pedersen Family and the Kidney Foundation of Canada (KFOC) are pleased to announce the availability of funding for basic science and clinical research that will enhance the understanding and treatment of Alport syndrome. This is the third year of joint collaboration to award funding for Alport syndrome research.
The Research Funding Program anticipates awarding two $100.000 research projects. Research proposals must be in accordance with the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program and applications are due March 23, 2015. There are no geographical limitations for this funding.
The purpose of the NBIA Disorders Association Research Grant Program is to encourage meritorious research studies designed to improve the diagnosis or treatment of NBIA. The research can be conducted in the United States, countries of the European Union, Canada, Australia, New Zealand, Brazil, Argentina, Chile, South Africa, Japan, or Israel, and in other countries where adequate supervision of grant administration is possible.
Evaluation of proposals will follow NIH guidelines and include careful consideration of experimental or protocol design, objectivity or relevance of parameters measured, and statistical analysis plan.
Our research priorities reflect our goal to find cures for NBIA disorders and the understanding that strategic work in basic, translational and clinical research will be required to reach this goal. We strive to accelerate the pace of discoveries that lead to new therapeutics by supporting pilot and high-risk projects. The projects we support are expected to generate essential resources for the scientific community, advance knowledge about NBIA disease processes, and produce preliminary data to enable national and international funding to carry the work forward.Back to top Clinical and Translational Science Awards (CTSA)
The CTSA program in the NCATS Division of Clinical Innovation supports a national consortium of medical research institutions that work together to improve the way clinical and translational research is conducted nationwide to enhance its efficiency and quality.Assay Development and High-Throughput Screening
The goal of the NIH Chemical Genomics Center's Assay Biology Teams in the NCATS Division of Pre-Clinical Innovation is to optimize biochemical, cellular and model organism-based assays requested or submitted by the biomedical research community for high-throughput small molecule screening.Bridging Interventional Development Gaps (BrIDGs)
BrIDGs makes available, on a competitive basis, certain critical resources needed for the development of new therapeutic agents.Chemistry Technology
NIH Chemical Genomics Center's Chemistry Technology Group in the NCATS Division of Pre-Clinical Innovation aims to solve fundamental problems and insufficiencies in molecular biology and drug discovery through investments in chemistry technology projects ranging from novel library design to inventive bioanalytical techniques.Molecular Libraries Probe Production Center
The NIH Chemical Genomics Center is one of the centers in the Molecular Libraries Probe Production Centers Network (MLPCN), which is an NIH Common Fund Initiative.NIH Chemical Genomics Center (NCGC)
The goals of NCGC in the NCATS Division of Pre-Clinical Innovation are to translate the discoveries of the Human Genome Project into biological and disease insights and ultimately new therapeutics for human disease through small molecule assay development, high-throughput screening, cheminformatics and chemistry.RNAi
NIH established a state-of-the-art RNAi screening facility administered by the NCATS Division of Pre-Clinical Innovation that accepts proposals from any intramural researcher.Therapeutics for Rare and Neglected Diseases (TRND)
The TRND program in the NCATS Division of Pre-Clinical Innovation aims to encourage and speed the development of new drugs for rare and neglected diseases.Toxicology in the 21st Century (Tox21)
The Tox21 program is a federal collaboration involving the NIH, Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) aimed at developing better toxicity assessment methods.Tissue Chip for Drug Screening
The Tissue Chip for Drug Screening initiative, which marks the first interagency collaboration launched by NCATS, aims to develop 3-D human tissue chips that accurately model the structure and function of human organs, such as the lung, liver and heart.Discovering New Therapeutic Uses for Existing Molecules
This collaborative pilot program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutic development.Back to top NCATS Open Funding Opportunities
Learn more about the funding and collaboration opportunities that NCATS offers.NCATS' Small Business Funding Programs
NCATS seeks to increase small business participation in federally supported research and development as well as private-sector commercialization of technology developed with federal support.Back to top